Physician profile
Emily Simon
NPI 1699159715
$1,189.55
in general payments reported to CMS, 2019-2025
19 companies · $73.88 in 2025
The $73.88 reported for 2025 was less than what a typical Clinical Nurse Specialist provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $324 · 2022: $195 · 2023: $337 · 2024: $259 · 2025: $73.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $316.15 | 2021-2025 | Minimed 780g |
| Dexcom, INC. | $223.18 | 2021-2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $143.95 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $86.11 | 2023-2024 | Freestyle Libre 3, Eterna, Proclaim |
| Radius Health, INC. | $74.56 | 2021-2024 | Tymlos |
| Lilly USA, LLC | $66.25 | 2021-2022 | |
| Insulet Corporation | $53.52 | 2021-2023 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.36 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $24.56 | 2023 | Gvoke Hypopen |
| Alvogen INC | $24.40 | 2023 | Teriparatide |
| Astrazeneca Pharmaceuticals LP | $21.71 | 2021 | |
| Abbvie INC. | $21.05 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.93 | 2023 | |
| Merck Sharp & Dohme LLC | $15.04 | 2021 | |
| Amarin Pharma, INC. | $14.30 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $12.64 | 2021 | |
| Amgen INC. | $12.41 | 2021 | |
| Acella Pharmaceuticals, LLC | $12.24 | 2022 | |
| Tandem Diabetes Care, INC. | $11.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.